These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7951512)

  • 1. Changes in plasma atrial natriuretic peptide during hemodialysis: mechanism of elevated levels in patients with chronic renal failure.
    Takagi T; Nishikawa M; Inada M
    Endocr J; 1993 Apr; 40(2):257-61. PubMed ID: 7951512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial natriuretic peptide (ANP) in patients with chronic renal failure on maintenance haemodialysis.
    de Châtel R; Makó J; Tóth M; Barna I; Lang RE
    Int Urol Nephrol; 1991; 23(2):177-83. PubMed ID: 1830872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in brain natriuretic peptide and atrial natriuretic peptide plasma concentrations during hemodialysis in patients with chronic renal failure.
    Haug C; Metzele A; Steffgen J; Grünert A
    Horm Metab Res; 1994 May; 26(5):246-9. PubMed ID: 8076909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased brain natriuretic peptide and atrial natriuretic peptide plasma concentrations in dialysis-dependent chronic renal failure and in patients with elevated left ventricular filling pressure.
    Haug C; Metzele A; Steffgen J; Kochs M; Hombach V; Grünert A
    Clin Investig; 1994 Jun; 72(6):430-4. PubMed ID: 7950153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment.
    Franz M; Woloszczuk W; Hörl WH
    Kidney Int; 2000 Jul; 58(1):374-83. PubMed ID: 10886584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical relevance of the determination of plasma atrial natriuretic peptide in children with chronic renal failure].
    Rascher W; Bald M; Kröner F; Tulassay T; Müller-Wiefel DE
    Z Kardiol; 1988; 77 Suppl 2():61-4. PubMed ID: 2970176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma concentrations of atrial natriuretic peptide, arginine vasopressin and hormones of the renin-angiotensin system in patients with end-stage renal disease.
    Elias AN; Vaziri ND; Pandian MR; Kaupke J
    Int J Artif Organs; 1989 Mar; 12(3):153-8. PubMed ID: 2526100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial natriuretic peptide plasma levels during hemodialysis and hemofiltration in patients with end-stage renal disease.
    Groll J; Hagemann J; Röhrich B; Schaefer K
    Int J Artif Organs; 1989 May; 12(5):284-8. PubMed ID: 2525530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma atrial natriuretic peptide during hemodialysis with or without fluid removal.
    Shiota J; Kubota M; Hamada C; Koide H
    Nephron; 1990; 55(3):283-6. PubMed ID: 2142515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of atrial natriuretic peptide in human blood.
    Yamaji T; Ishibashi M; Takaku F; Sato F; Kamoi K; Nakaoka H; Fujii J; Hasegawa K; Morii H
    Jpn J Med; 1987 May; 26(2):207-11. PubMed ID: 2957532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of atrial natriuretic peptide in patients with chronic renal failure.
    Hasegawa K; Matsushita Y; Inoue T; Morii H; Ishibashi M; Yamaji T
    J Clin Endocrinol Metab; 1986 Oct; 63(4):819-22. PubMed ID: 2943754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelin and atrial natriuretic peptide in non-insulin-dependent diabetic versus nondiabetic patients on chronic hemodialysis.
    Schleiffer T; Nagel D; Franz H; Falk M; Valentiner I; Wildburg G; Stark M; Brass H
    Ren Fail; 1994 Nov; 16(6):747-58. PubMed ID: 7899586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adsorption of natriuretic factors in uremia.
    Franz M; Woloszczuk W; Hörl WH
    Semin Nephrol; 2001 May; 21(3):298-302. PubMed ID: 11320498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of volume overload in dialysis-refractory hypertension.
    Fishbane S; Natke E; Maesaka JK
    Am J Kidney Dis; 1996 Aug; 28(2):257-61. PubMed ID: 8768921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digitalislike immunoreactive substances and extracellular fluid volume status in chronic hemodialysis patients.
    Bisordi JE; Holt S
    Am J Kidney Dis; 1989 May; 13(5):396-403. PubMed ID: 2541609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central blood volume, atrial natriuretic peptide and intermittent hemodialysis.
    Wallin CJ; Rossi P; Jacobson SH; Leksell LG
    Scand J Urol Nephrol; 2004; 38(1):78-84. PubMed ID: 15204432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma atrial natriuretic peptide in patients with chronic renal failure.
    Chen JH; Tsai JH; Lai YH; Hwang SJ
    J Formos Med Assoc; 1990 Aug; 89(8):645-50. PubMed ID: 1981224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of haemodialysis and haemofiltration on plasma atrial natriuretic peptide.
    Raine AE; Bock A; Muller FB; Erne P; Bolli P; Brunner F; Buhler FR
    Nephrol Dial Transplant; 1989; 4(3):222-7. PubMed ID: 2524680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial natriuretic peptide and volume changes in children.
    Tulassay T; Rascher W; Ganten D; Schärer K; Lang RE
    Clin Exp Hypertens A; 1986; 8(4-5):695-701. PubMed ID: 2944674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial natriuretic peptide in plasma of volume-overloaded children with chronic renal failure.
    Rascher W; Tulassay T; Lang RE
    Lancet; 1985 Aug; 2(8450):303-5. PubMed ID: 2862469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.